Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

William S. Messer

Showing results (21-30 of 32) with videos related to

Pageof 4
Sort By:
ACS Chemical Neuroscience|July 12, 2023
The Partial M<sub>1</sub> Muscarinic Cholinergic Receptor Agonist, CDD-0102A, Differentially Modulates Glutamate Efflux in Striatal Subregions during Stereotyped Motor Behavior in the BTBR Mouse Model of AutismPamela Teneqexhi, Alina Khalid, Khalin E Nisbett, et al.
Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences|July 9, 2002
Internal standard method for the measurement of choline and acetylcholine by capillary electrophoresis with electrochemical detectionDana D Wise, Tatyana V Barkhimer, Pierre-Alexandre Brault, et al.
Journal of Neurochemistry|November 9, 2002
Functional characterization of alternatively spliced 5-HT2 receptor isoforms from the pharynx and muscle of the parasitic nematode, Ascaris suumXinyan Huang, Hong Xiao, Elizabeth B Rex, et al.
Journal of the American Geriatrics Society|January 10, 2006
Antimuscarinic drugs for overactive bladder and their potential effects on cognitive function in older patientsGary G Kay, Mohamed B Abou-Donia, William S Messer, et al.
Neurobiology of Aging|November 3, 2024
M1 muscarinic receptor activation reverses age-related memory updating impairment in miceKristen H Jardine, Emily P Minard, Cassidy E Wideman, et al.
Brain Sciences|September 27, 2025
Primary Cilia and Cardiovascular Risk Factors in Alzheimer's DiseaseClare L Sunderman, Kathleen V Forero, Qasim Alorjani, et al.
Journal of Medicinal Chemistry|December 8, 2006
Design and synthesis of novel derivatives of the muscarinic agonist tetra(ethylene glycol)(3-methoxy-1,2,5-thiadiazol-4-yl) [3-(1-methyl-1,2,5,6-tetrahydropyrid-3-yl)-1,2,5-thiadiazol-4-yl] ether (CDD-0304): effects of structural modifications on the binding and activity at muscarinic receptor subtypes and chimerasFrederick R Tejada, Peter I Nagy, Min Xu, et al.
Journal of Medicinal Chemistry|September 19, 2003
Synthesis and biological characterization of 1-methyl-1,2,5,6-tetrahydropyridyl-1,2,5-thiadiazole derivatives as muscarinic agonists for the treatment of neurological disordersYang Cao, Minjia Zhang, Cindy Wu, et al.
Scientific Reports|June 28, 2024
Allosteric modulators of M<sub>1</sub> muscarinic receptors enhance acetylcholine efficacy and decrease locomotor activity and turning behaviors in zebrafishCorey J Widman, Sestina Ventresca, Jillian Dietrich, et al.
Research Square|February 27, 2024
Hybrid Allosteric Modulators of M1 Muscarinic Receptors Enhance Acetylcholine Efficacy and Decrease Locomotor Activity and Turning Behaviors in ZebrafishCorey J Widman, Sestina Ventresca, Jillian Dietrich, et al.
Pageof 4

Showing results (21-30 of 32) with videos related to

Sort By:
Pageof 4
ACS Chemical Neuroscience|July 12, 2023
The Partial M<sub>1</sub> Muscarinic Cholinergic Receptor Agonist, CDD-0102A, Differentially Modulates Glutamate Efflux in Striatal Subregions during Stereotyped Motor Behavior in the BTBR Mouse Model of AutismPamela Teneqexhi, Alina Khalid, Khalin E Nisbett, et al.
Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences|July 9, 2002
Internal standard method for the measurement of choline and acetylcholine by capillary electrophoresis with electrochemical detectionDana D Wise, Tatyana V Barkhimer, Pierre-Alexandre Brault, et al.
Journal of Neurochemistry|November 9, 2002
Functional characterization of alternatively spliced 5-HT2 receptor isoforms from the pharynx and muscle of the parasitic nematode, Ascaris suumXinyan Huang, Hong Xiao, Elizabeth B Rex, et al.
Journal of the American Geriatrics Society|January 10, 2006
Antimuscarinic drugs for overactive bladder and their potential effects on cognitive function in older patientsGary G Kay, Mohamed B Abou-Donia, William S Messer, et al.
Neurobiology of Aging|November 3, 2024
M1 muscarinic receptor activation reverses age-related memory updating impairment in miceKristen H Jardine, Emily P Minard, Cassidy E Wideman, et al.
Brain Sciences|September 27, 2025
Primary Cilia and Cardiovascular Risk Factors in Alzheimer's DiseaseClare L Sunderman, Kathleen V Forero, Qasim Alorjani, et al.
Journal of Medicinal Chemistry|December 8, 2006
Design and synthesis of novel derivatives of the muscarinic agonist tetra(ethylene glycol)(3-methoxy-1,2,5-thiadiazol-4-yl) [3-(1-methyl-1,2,5,6-tetrahydropyrid-3-yl)-1,2,5-thiadiazol-4-yl] ether (CDD-0304): effects of structural modifications on the binding and activity at muscarinic receptor subtypes and chimerasFrederick R Tejada, Peter I Nagy, Min Xu, et al.
Journal of Medicinal Chemistry|September 19, 2003
Synthesis and biological characterization of 1-methyl-1,2,5,6-tetrahydropyridyl-1,2,5-thiadiazole derivatives as muscarinic agonists for the treatment of neurological disordersYang Cao, Minjia Zhang, Cindy Wu, et al.
Scientific Reports|June 28, 2024
Allosteric modulators of M<sub>1</sub> muscarinic receptors enhance acetylcholine efficacy and decrease locomotor activity and turning behaviors in zebrafishCorey J Widman, Sestina Ventresca, Jillian Dietrich, et al.
Research Square|February 27, 2024
Hybrid Allosteric Modulators of M1 Muscarinic Receptors Enhance Acetylcholine Efficacy and Decrease Locomotor Activity and Turning Behaviors in ZebrafishCorey J Widman, Sestina Ventresca, Jillian Dietrich, et al.
Pageof 4